Clinical trial shows ‘Shared Care’ model safe for patients after donor stem cell transplant

Patients undergoing a donor stem-cell transplant for leukemia or other blood-related cancer require months of specialized follow-up care, traditionally delivered at the center where they received their transplant—often a serious challenge for those who live far away. A large clinical trial by Dana-Farber Cancer Institute investigators shows that patients can fare just as well when they receive some of this care at a local hematology/oncology clinic.

Alcohol raises colorectal cancer risk while calcium protects, study finds

Researchers from the Cancer Epidemiology Unit at the University of Oxford, along with collaborators from international institutions, found significant associations between diet and colorectal cancer risk. Examining data from 542,778 women in the United Kingdom, the study identified a positive correlation between alcohol consumption and colorectal cancer and a protective role for calcium and dairy-related foods.

UV light–based cell therapy offers new hope for lung transplant patients, reducing rejection and infection risks

Researchers from the Vienna Lung Transplant Program of MedUni Vienna and University Hospital Vienna have published the first prospective, randomized and controlled study on the use of extracorporeal photopheresis (ECP) in lung transplantation in the European Respiratory Journal. The findings could significantly change the standard procedure for rejection reactions after lung transplants.